From Bloomberg Philanthropies <[email protected]>
Subject Got questions about vaccines?
Date December 23, 2020 5:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
We've got 10 (more) answers from a public health expert. 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 

<[link removed]>

John,

Back in October, we shared our first "10 Questions on Vaccines" video, with
expert insights on the development of a COVID-19 vaccine.

It's safe to say that a lot has happened since then -- including the approval
and distribution of two new vaccines -- so we're back with 10 more questions,
and 10 more answers.

<[link removed]>

WATCH NOW <[link removed]>

SHARE ON FACEBOOK
<[link removed]>

SHARE ON TWITTER
<[link removed]>
This time, Dr. Rupali J. Limaye, an expert in vaccine behavior and
decision-making at the Johns Hopkins Bloomberg School of Public Health, fields
the questions, covering inquiries on what "emergency authorization" entails,
what a vaccine means for getting us back to normal, how to talk to people about
vaccine fears, and more.

Take a few minutes to watch the Q&A with Dr. Limaye -- and share with anyone
you know who might have vaccine questions and could benefit from the
perspectives of a public health expert.

Thanks,

Bloomberg Philanthropies

P.S. -- In case you missed it, here's that first "10 Questions on Vaccines"
video with Bloomberg Philanthropies Public Health lead and epidemiologist Dr.
Kelly Henning:[link removed] <[link removed]>


 

<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>  
Click here to unsubscribe
<[link removed]>
.

Bloomberg Philanthropies

All content © 2020. All rights reserved.
Screenshot of the email generated on import

Message Analysis